-
1
-
-
35549010225
-
Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists
-
J.R. Curtis, J.M. Kramer, C. Martin, K.G. Saag, N. Patkar, and G. Satin Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists Rheumatology 46 2007 1688 1693
-
(2007)
Rheumatology
, vol.46
, pp. 1688-1693
-
-
Curtis, J.R.1
Kramer, J.M.2
Martin, C.3
Saag, K.G.4
Patkar, N.5
Satin, G.6
-
2
-
-
34547742119
-
Cardiac involvement in systemic inflammatory diseases
-
D.C. Knockaert Cardiac involvement in systemic inflammatory diseases Eur Heart J 28 2007 1797 1804
-
(2007)
Eur Heart J
, vol.28
, pp. 1797-1804
-
-
Knockaert, D.C.1
-
3
-
-
0034754477
-
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
-
W.J. Sandborn, S.B. Hanauer, S. Katz, M. Safdi, D.G. Wolf, and R.D. Baerg Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial Gastroenterology 121 2001 1088 1094
-
(2001)
Gastroenterology
, vol.121
, pp. 1088-1094
-
-
Sandborn, W.J.1
Hanauer, S.B.2
Katz, S.3
Safdi, M.4
Wolf, D.G.5
Baerg, R.D.6
-
4
-
-
1842632413
-
Anti-tumor necrosis factor alpha therapy and heart failure - What have we learned and where do we go from here?
-
D. Khanna, M. McMahon, and D.E. Furst Anti-tumor necrosis factor alpha therapy and heart failure - what have we learned and where do we go from here? Arthritis Rheum 4 2004 1040 1050
-
(2004)
Arthritis Rheum
, vol.4
, pp. 1040-1050
-
-
Khanna, D.1
McMahon, M.2
Furst, D.E.3
-
5
-
-
0037195727
-
Inflammatory mediators and the failing heart: Past, present, and the foreseeable future
-
D.L. Mann Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ Res 91 2002 988 998
-
(2002)
Circ Res
, vol.91
, pp. 988-998
-
-
Mann, D.L.1
-
6
-
-
1642463859
-
Inflammatory mediators in chronic heart failure: An overview
-
S.D. Anker, and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
-
(2004)
Heart
, vol.90
, pp. 464-470
-
-
Anker, S.D.1
Von Haehling, S.2
-
7
-
-
0025286817
-
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
-
B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
-
(1990)
N Engl J Med
, vol.323
, pp. 236-241
-
-
Levine, B.1
Kalman, J.2
Mayer, L.3
Fillit, H.M.4
Packer, M.5
-
8
-
-
0027483722
-
Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
-
T. Yokoyama, L. Vaca, R.D. Rossen, W. Durante, P. Hazarika, and D.L. Mann Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart J Clin Invest 92 1993 2303 2312
-
(1993)
J Clin Invest
, vol.92
, pp. 2303-2312
-
-
Yokoyama, T.1
Vaca, L.2
Rossen, R.D.3
Durante, W.4
Hazarika, P.5
Mann, D.L.6
-
9
-
-
0032515950
-
Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats
-
B. Bozkurt, S.B. Kribbs, F.J. Clubb Jr., L.H. Michael, V.V. Didenko, and P.J. Hornsby Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1998 1382 1391
-
(1998)
Circulation
, vol.97
, pp. 1382-1391
-
-
Bozkurt, B.1
Kribbs, S.B.2
Clubb, Jr.F.J.3
Michael, L.H.4
Didenko, V.V.5
Hornsby, P.J.6
-
10
-
-
0026779727
-
Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs
-
F.D. Pagani, L.S. Baker, C. Hsi, M. Knox, M.P. Fink, and M.S. Visner Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs J Clin Invest 90 1992 389 398
-
(1992)
J Clin Invest
, vol.90
, pp. 389-398
-
-
Pagani, F.D.1
Baker, L.S.2
Hsi, C.3
Knox, M.4
Fink, M.P.5
Visner, M.S.6
-
11
-
-
58149130150
-
Immune modulation: Role of the inflammatory cytokine cascade in the failing human heart
-
M. Satoh, Y. Minami, Y. Takahashi, and M. Nakamura Immune modulation: role of the inflammatory cytokine cascade in the failing human heart Curr Heart Fail Rep 5 2008 69 74
-
(2008)
Curr Heart Fail Rep
, vol.5
, pp. 69-74
-
-
Satoh, M.1
Minami, Y.2
Takahashi, Y.3
Nakamura, M.4
-
12
-
-
0343875590
-
Interleukin 1 and tumor necrosis factor inhibit myocyte b-adrenergic responsiveness
-
T. Gulick, M.K. Chung, S.J. Pieper, L.G. Lange, and G.F. Schreiner Interleukin 1 and tumor necrosis factor inhibit myocyte b-adrenergic responsiveness Proc Natl Acad Sci 86 1989 6753 6757
-
(1989)
Proc Natl Acad Sci
, vol.86
, pp. 6753-6757
-
-
Gulick, T.1
Chung, M.K.2
Pieper, S.J.3
Lange, L.G.4
Schreiner, G.F.5
-
13
-
-
4744348381
-
In vivo TNF-A inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure
-
G.W. Moe, J. Marin-Garcia, A. Konig, M. Goldenthal, X. Lu, and Q. Feng In vivo TNF-a inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure Am J Physiol Heart Circ Physiol 287 2004 H1813 H1820
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
-
-
Moe, G.W.1
Marin-Garcia, J.2
Konig, A.3
Goldenthal, M.4
Lu, X.5
Feng, Q.6
-
14
-
-
0029975877
-
Tumor necrosis factor a and interleukin 1b are responsible for in vitro myocardial cell depression induced by human septic shock serum
-
A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz, and J.E. Parrillo Tumor necrosis factor a and interleukin 1b are responsible for in vitro myocardial cell depression induced by human septic shock serum J Exp Med 183 1996 949 958
-
(1996)
J Exp Med
, vol.183
, pp. 949-958
-
-
Kumar, A.1
Thota, V.2
Dee, L.3
Olson, J.4
Uretz, E.5
Parrillo, J.E.6
-
16
-
-
0034808012
-
Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo
-
M. Patten, E. Krämer, J. Bünemann, C. Wenck, M. Thoenes, and T. Wieland Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo Pflugers Arch - Eur J Physiol 442 2001 920 927
-
(2001)
Pflugers Arch - Eur J Physiol
, vol.442
, pp. 920-927
-
-
Patten, M.1
Krämer, E.2
Bünemann, J.3
Wenck, C.4
Thoenes, M.5
Wieland, T.6
-
17
-
-
78650971588
-
TNF alpha in myocardial ischemia/reperfusion, remodeling and heart failure
-
P. Kleinbogard, R. Schulz, and G. Heusch TNF alpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Fail Rev 16 2011 49 69
-
(2011)
Heart Fail Rev
, vol.16
, pp. 49-69
-
-
Kleinbogard, P.1
Schulz, R.2
Heusch, G.3
-
18
-
-
0037022910
-
Inflammation and atherosclerosis
-
P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
-
(2002)
Circulation
, vol.105
, pp. 1135-1143
-
-
Libby, P.1
Ridker, P.M.2
Maseri, A.3
-
19
-
-
20044381106
-
Tumor necrosis factor-A receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study
-
M. Valgimigli, C. Ceconi, P. Malagutti, E. Merli, O. Soukhomovskaia, and G. Francolini Tumor necrosis factor-a receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study Circulation 111 2005 863 870
-
(2005)
Circulation
, vol.111
, pp. 863-870
-
-
Valgimigli, M.1
Ceconi, C.2
Malagutti, P.3
Merli, E.4
Soukhomovskaia, O.5
Francolini, G.6
-
20
-
-
54549110222
-
Common community infections and the risk for coronary artery disease and acute myocardial infarction: Evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1
-
A. Nikolopoulou, D. Tousoulis, C. Antoniades, K. Petroheilou, C. Vasiliadou, and N. Papageorgiou Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1 Int J Cardiol 130 2008 246 250
-
(2008)
Int J Cardiol
, vol.130
, pp. 246-250
-
-
Nikolopoulou, A.1
Tousoulis, D.2
Antoniades, C.3
Petroheilou, K.4
Vasiliadou, C.5
Papageorgiou, N.6
-
21
-
-
33645538914
-
C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study
-
K. Tuomisto, P. Jousilahti, J. Sundvall, P. Pajunen, and V. Salomaa C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study Thromb Haemost 95 2006 511 518
-
(2006)
Thromb Haemost
, vol.95
, pp. 511-518
-
-
Tuomisto, K.1
Jousilahti, P.2
Sundvall, J.3
Pajunen, P.4
Salomaa, V.5
-
22
-
-
70749088135
-
Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
-
W. Dinh, R. Futh, W. Nickl, T. Krahn, P. Ellinghaus, and T. Scheffold Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders Cardiovasc Diabetol 8 2009 58
-
(2009)
Cardiovasc Diabetol
, vol.8
, pp. 58
-
-
Dinh, W.1
Futh, R.2
Nickl, W.3
Krahn, T.4
Ellinghaus, P.5
Scheffold, T.6
-
23
-
-
70350074632
-
Plasma concentrations of TNF-A and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease
-
K. Safranow, V. Dziedziejko, R. Rzeuski, E. Czyzycka, A. Wojtarowicz, and A. Binczak-Kuleta Plasma concentrations of TNF-a and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease Tissue Antigens 74 2009 386 392
-
(2009)
Tissue Antigens
, vol.74
, pp. 386-392
-
-
Safranow, K.1
Dziedziejko, V.2
Rzeuski, R.3
Czyzycka, E.4
Wojtarowicz, A.5
Binczak-Kuleta, A.6
-
24
-
-
0037465808
-
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction
-
R.S. Vasan, L.M. Sullivan, R. Roubenoff, C.A. Dinarello, T. Harris, and E.J. Benjamin Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction Circulation 107 2003 1486 1491
-
(2003)
Circulation
, vol.107
, pp. 1486-1491
-
-
Vasan, R.S.1
Sullivan, L.M.2
Roubenoff, R.3
Dinarello, C.A.4
Harris, T.5
Benjamin, E.J.6
-
25
-
-
77950506582
-
Inflammatory cytokines in heart failure: Roles in aetiology and utility as biomarkers
-
L. Tamariz, and J.M. Hare Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers Eur Heart J 31 2010 768 770
-
(2010)
Eur Heart J
, vol.31
, pp. 768-770
-
-
Tamariz, L.1
Hare, J.M.2
-
26
-
-
0035942264
-
Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST)
-
A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST) Circulation 103 2001 2055 2059
-
(2001)
Circulation
, vol.103
, pp. 2055-2059
-
-
Deswal, A.1
Petersen, N.J.2
Feldman, A.M.3
Young, J.B.4
White, B.G.5
Mann, D.L.6
-
27
-
-
0029117828
-
Tumor necrosis factor solubile receptors in patients with various degrees of congestive heart failure
-
R. Ferrari, T. Bachetti, R. Confortini, C. Opasich, O. Febo, and A. Corti Tumor necrosis factor solubile receptors in patients with various degrees of congestive heart failure Circulation 92 1995 1479 1486
-
(1995)
Circulation
, vol.92
, pp. 1479-1486
-
-
Ferrari, R.1
Bachetti, T.2
Confortini, R.3
Opasich, C.4
Febo, O.5
Corti, A.6
-
28
-
-
0034687595
-
Plasma cytokine parameters and mortality in patients with chronic heart failure
-
M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, and C. Liebenthal Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
-
(2000)
Circulation
, vol.102
, pp. 3060-3067
-
-
Rauchhaus, M.1
Doehner, W.2
Francis, D.P.3
Davos, C.4
Kemp, M.5
Liebenthal, C.6
-
29
-
-
77954242107
-
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
-
P. Kleinbogard, R. Schulz, and G. Heusch TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure Pharmacol Ther 127 2010 295 314
-
(2010)
Pharmacol Ther
, vol.127
, pp. 295-314
-
-
Kleinbogard, P.1
Schulz, R.2
Heusch, G.3
-
30
-
-
0033614816
-
Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
-
A. Deswal, B. Bozkurt, Y. Seta, F. Parilti-Eiswirth, F. Ann Hayes, and D.L. Mann Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure Circulation 99 1999 3224 3226
-
(1999)
Circulation
, vol.99
, pp. 3224-3226
-
-
Deswal, A.1
Bozkurt, B.2
Seta, Y.3
Parilti-Eiswirth, F.4
Ann Hayes, F.5
Mann, D.L.6
-
31
-
-
0035957036
-
Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
-
B. Bozkurt, G. Torre-Amione, M.S. Warren, J. Whitmore, O.Z. Soren, and A.M. Feldman Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure Circulation 103 2001 1044 1047
-
(2001)
Circulation
, vol.103
, pp. 1044-1047
-
-
Bozkurt, B.1
Torre-Amione, G.2
Warren, M.S.3
Whitmore, J.4
Soren, O.Z.5
Feldman, A.M.6
-
32
-
-
0036888364
-
How to RECOVER from RENAISSANCE? the significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
-
S.D. Anker, and A.J. Coats How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH Int J Cardiol 86 2002 123 130
-
(2002)
Int J Cardiol
, vol.86
, pp. 123-130
-
-
Anker, S.D.1
Coats, A.J.2
-
34
-
-
11144355760
-
Targeted anticytokine therapy in patients with chronic heart failure. Results of the randomized etanercept worldwide evaluation (RENEWAL)
-
D.L. Mann, J.J.V. McMurray, M. Packer, K. Swedberg, J.S. Borer, and W.S. Colucci Targeted anticytokine therapy in patients with chronic heart failure. Results of the randomized etanercept worldwide evaluation (RENEWAL) Circulation 109 2004 1594 1602
-
(2004)
Circulation
, vol.109
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.V.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
-
35
-
-
0035806902
-
Anti-tumor necrosis factor-A antibody limits heart failure in a transgenic model
-
T. Kadokami, C. Frye, B. Lemster, C.L. Wagner, A.M. Feldman, and C.F. McTiernan Anti-tumor necrosis factor-a antibody limits heart failure in a transgenic model Circulation 104 2001 1094 1097
-
(2001)
Circulation
, vol.104
, pp. 1094-1097
-
-
Kadokami, T.1
Frye, C.2
Lemster, B.3
Wagner, C.L.4
Feldman, A.M.5
McTiernan, C.F.6
-
36
-
-
0038755661
-
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-A, in patients with moderate-to-severe heart failure
-
E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, and J.T. Willerson Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-a, in patients with moderate-to-severe heart failure Circulation 107 2003 3133 3140
-
(2003)
Circulation
, vol.107
, pp. 3133-3140
-
-
Chung, E.S.1
Packer, M.2
Lo, K.H.3
Fasanmade, A.A.4
Willerson, J.T.5
-
37
-
-
0011168402
-
Effects of cytokine antagonism with etanercept on morbidity and mortality in chronic heart failure:results of the randomized etanercept world-wide evaluation (RENEWAL) trial
-
J. McMurray, and D.L. Mann Effects of cytokine antagonism with etanercept on morbidity and mortality in chronic heart failure:results of the randomized etanercept world-wide evaluation (RENEWAL) trial Heart Failure 2002 Meeting. Hot Line Session. Oral presentation, Oslo/Norway,10th June, 2002 2002
-
(2002)
Heart Failure 2002 Meeting. Hot Line Session. Oral Presentation, Oslo/Norway,10th June, 2002
-
-
McMurray, J.1
Mann, D.L.2
-
38
-
-
84894883299
-
A phase II, multicenter, randomized, double-blind, placebo-controlled pilot trial evaluating the effects of infliximab (Remicade) in patients with stable class III or IV congestive heart failure ("ATTACH")
-
M. Packer A phase II, multicenter, randomized, double-blind, placebo-controlled pilot trial evaluating the effects of infliximab (Remicade) in patients with stable class III or IV congestive heart failure ("ATTACH") Heart Failure 2002 Meeting. Hot Line Session. Oral presentation, Oslo/Norway, 10th June, 2002 2002
-
(2002)
Heart Failure 2002 Meeting. Hot Line Session. Oral Presentation, Oslo/Norway, 10th June, 2002
-
-
Packer, M.1
-
39
-
-
78649912194
-
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease
-
A. Orlando, A. Armuzzi, C. Papi, V. Annese, S. Ardizzone, and L. Biancone The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease Dig Liver Dis 43 2011 1 20
-
(2011)
Dig Liver Dis
, vol.43
, pp. 1-20
-
-
Orlando, A.1
Armuzzi, A.2
Papi, C.3
Annese, V.4
Ardizzone, S.5
Biancone, L.6
-
40
-
-
67650088393
-
Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropaties: A retrospective study
-
D. Fouache, V. Goeb, N. Nassy-Guillemant, G. Avenel, H. Bacquet-Deschryver, and M. Kozyreff-Meurice Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropaties: a retrospective study Rheumatology 48 2009 761 764
-
(2009)
Rheumatology
, vol.48
, pp. 761-764
-
-
Fouache, D.1
Goeb, V.2
Nassy-Guillemant, N.3
Avenel, G.4
Bacquet-Deschryver, H.5
Kozyreff-Meurice, M.6
-
41
-
-
0036229685
-
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
-
S. Van Doornum, G. McColl, and I.P. Wicks Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46 2002 862 873
-
(2002)
Arthritis Rheum
, vol.46
, pp. 862-873
-
-
Van Doornum, S.1
McColl, G.2
Wicks, I.P.3
-
42
-
-
77956925678
-
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
-
F. Atzeni, M. Turiel, and R. Caporali The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases Autoimmun Rev 9 2010 835 839
-
(2010)
Autoimmun Rev
, vol.9
, pp. 835-839
-
-
Atzeni, F.1
Turiel, M.2
Caporali, R.3
-
43
-
-
0035676529
-
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
-
I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, and A. Escalante High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2737-2745
-
-
Del Rincon, I.1
Williams, K.2
Stern, M.P.3
Freeman, G.L.4
Escalante, A.5
-
44
-
-
13444294254
-
The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years
-
P.J. Nicola, H. Maradit-Kremers, V.L. Roger, S.J. Jacobsen, C.S. Crowson, and K.V. Ballman The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis Rheum 52 2005 412 420
-
(2005)
Arthritis Rheum
, vol.52
, pp. 412-420
-
-
Nicola, P.J.1
Maradit-Kremers, H.2
Roger, V.L.3
Jacobsen, S.J.4
Crowson, C.S.5
Ballman, K.V.6
-
45
-
-
0037643388
-
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database
-
D.J. Watson, T. Rhodes, and H.A. Guess All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database J Rheumatol 30 2003 1196 1202
-
(2003)
J Rheumatol
, vol.30
, pp. 1196-1202
-
-
Watson, D.J.1
Rhodes, T.2
Guess, H.A.3
-
46
-
-
28544447858
-
Disease modification and cardiovascular risk reduction: Two sides of the same coin?
-
F.C. Hall, and N. Dalbeth Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 44 2005 1473 1482
-
(2005)
Rheumatology
, vol.44
, pp. 1473-1482
-
-
Hall, F.C.1
Dalbeth, N.2
-
47
-
-
1242315583
-
Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
-
F. Wolfe, and K. Michaud Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy Am J Med 116 2004 305 311
-
(2004)
Am J Med
, vol.116
, pp. 305-311
-
-
Wolfe, F.1
Michaud, K.2
-
48
-
-
40549134937
-
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
-
J. Listing, A. Strangfeld, J. Kekow, M. Schneider, A. Kapelle, and S. Wassenberg Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58 2008 667 677
-
(2008)
Arthritis Rheum
, vol.58
, pp. 667-677
-
-
Listing, J.1
Strangfeld, A.2
Kekow, J.3
Schneider, M.4
Kapelle, A.5
Wassenberg, S.6
-
49
-
-
22244443784
-
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
-
L.T. Jacobsson, C. Turesson, A. Gülfe, M.C. Kapetanovic, I.F. Petersson, and T. Saxne Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis J Rheumatol 32 2005 1213 1218
-
(2005)
J Rheumatol
, vol.32
, pp. 1213-1218
-
-
Jacobsson, L.T.1
Turesson, C.2
Gülfe, A.3
Kapetanovic, M.C.4
Petersson, I.F.5
Saxne, T.6
-
50
-
-
34848898513
-
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: Results from the British Society for Rheumatology Biologics Register
-
W.G. Dixon, K.D. Watson, M. Lunt, K.L. Hyrich, British Society for Rheumatology Biologics Register Control Centre Consortium, and A.J. Silman Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2007 2905 2912
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2905-2912
-
-
Dixon, W.G.1
Watson, K.D.2
Lunt, M.3
Hyrich, K.L.4
-
51
-
-
16844372053
-
TNF-alpha, rheumatoid arthritis, and heart failure: A rheumatological dilemma
-
P. Sarzi-Puttini, F. Atzeni, Y. Shoenfeld, and G. Ferraccioli TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma Autoimmun Rev 4 2005 153 161
-
(2005)
Autoimmun Rev
, vol.4
, pp. 153-161
-
-
Sarzi-Puttini, P.1
Atzeni, F.2
Shoenfeld, Y.3
Ferraccioli, G.4
-
52
-
-
4243874480
-
Association of ulcerative colitis and ischemic heart disease
-
H. Nuutinen, M. Reunanen, and M. Farrkkila Association of ulcerative colitis and ischemic heart disease Gastroenterology 108A 1995 886
-
(1995)
Gastroenterology
, vol.108 A
, pp. 886
-
-
Nuutinen, H.1
Reunanen, M.2
Farrkkila, M.3
-
53
-
-
0004545156
-
Association of Crohn's disease and ischemic heart disease
-
H. Nuutinen, M. Reunanen, and M. Farrkkila Association of Crohn's disease and ischemic heart disease Gastroenterology 110A 1996 981
-
(1996)
Gastroenterology
, vol.110 A
, pp. 981
-
-
Nuutinen, H.1
Reunanen, M.2
Farrkkila, M.3
-
54
-
-
66949138571
-
Risk of arterial thrombotic events in inflammatory bowel disease
-
C. Ha, S. Magowan, N.A. Accort, J. Chen, and C.D. Stone Risk of arterial thrombotic events in inflammatory bowel disease Am J Gastroenterol 104 2009 1445 1451
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1445-1451
-
-
Ha, C.1
Magowan, S.2
Accort, N.A.3
Chen, J.4
Stone, C.D.5
-
55
-
-
34247895393
-
Inflammatory bowel disease is not associated with increased intimal media thickening
-
N. Maharshak, Y. Arbel, N.M. Bornstein, A. Gal-Oz, A.Y. Gur, and I. Shapira Inflammatory bowel disease is not associated with increased intimal media thickening Am J Gastroenterol 102 2006 1050 1055
-
(2006)
Am J Gastroenterol
, vol.102
, pp. 1050-1055
-
-
Maharshak, N.1
Arbel, Y.2
Bornstein, N.M.3
Gal-Oz, A.4
Gur, A.Y.5
Shapira, I.6
-
56
-
-
27644460489
-
Increased carotid intima-media thickness in patients with inflammatory bowel disease
-
A. Papa, A. Santoliquido, S. Danese, M. Covino, C. Di Campli, and R. Urgesi Increased carotid intima-media thickness in patients with inflammatory bowel disease Aliment Pharmacol Ther 22 2005 839 846
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 839-846
-
-
Papa, A.1
Santoliquido, A.2
Danese, S.3
Covino, M.4
Di Campli, C.5
Urgesi, R.6
-
57
-
-
27744546460
-
Thrombosis in inflammatory bowel disease: Role of inherited thrombophilia
-
L. Spina, S. Saibeni, and T. Battaglioli Thrombosis in inflammatory bowel disease: role of inherited thrombophilia Am J Gastroenterol 100 2005 2036 2041
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 2036-2041
-
-
Spina, L.1
Saibeni, S.2
Battaglioli, T.3
-
58
-
-
25444497459
-
Systemic thromboembolism in inflammatory bowel disease: Mechanisms and clinical applications
-
G. Twig, G. Zandman-Goddard, and M. Szyper-Kravitz Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications Ann N Y Acad Sci 1051 2005 166 173
-
(2005)
Ann N y Acad Sci
, vol.1051
, pp. 166-173
-
-
Twig, G.1
Zandman-Goddard, G.2
Szyper-Kravitz, M.3
-
59
-
-
0141609935
-
Inflammation and thrombosis
-
C.T. Esmon Inflammation and thrombosis J Thromb Haemost 1 2003 1343 1348
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1343-1348
-
-
Esmon, C.T.1
-
60
-
-
33846542418
-
Mutations in clotting factors and inflammatory bowel disease
-
C.N. Bernstein, M. Sargent, and H.L. Vos Mutations in clotting factors and inflammatory bowel disease Am J Gastroenterol 102 2007 338 343
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 338-343
-
-
Bernstein, C.N.1
Sargent, M.2
Vos, H.L.3
-
61
-
-
0030895756
-
Thrombosis in inflamatory bowel disease: Clinical setting, procoagulant proB le and Factor v Leiden
-
L.M. Jackson, P.J. O'Gorman, J. O'Connell, C.C. Cronin, K.P. Cotter, and F. Shanahan Thrombosis in inflamatory bowel disease: clinical setting, procoagulant proB le and Factor V Leiden Q J Med 90 1997 183 188
-
(1997)
Q J Med
, vol.90
, pp. 183-188
-
-
Jackson, L.M.1
O'Gorman, P.J.2
O'Connell, J.3
Cronin, C.C.4
Cotter, K.P.5
Shanahan, F.6
-
62
-
-
0035216261
-
Increased levels of lipoprotein (a) in Crohn's disease: A relation to thrombosis?
-
I.E. Koutroubakis, N. Malliaraki, E. Vardas, E. Ganotakis, A.N. Margioris, and O.N. Manousos Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis? Eur J Gastroenterol Hepatol 13 2001 1415 1419
-
(2001)
Eur J Gastroenterol Hepatol
, vol.13
, pp. 1415-1419
-
-
Koutroubakis, I.E.1
Malliaraki, N.2
Vardas, E.3
Ganotakis, E.4
Margioris, A.N.5
Manousos, O.N.6
-
63
-
-
34247552113
-
Genetic risk factors in patients with inflammatory bowel disease and vascular complications: Case-control study
-
I.E. Koutroubakis, A. Sfiridaki, G. Tsiolakidou, A. Theodoropoulou, A. Livadiotaki, and G. Paspatis Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control study Inflamm Bowel Dis 13 2007 410 415
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 410-415
-
-
Koutroubakis, I.E.1
Sfiridaki, A.2
Tsiolakidou, G.3
Theodoropoulou, A.4
Livadiotaki, A.5
Paspatis, G.6
-
64
-
-
66949150330
-
Homocysteine in inflamatory bowel disease: A risk factor for thromboembolic complications?
-
B. Oldenburg, R. Fijnheer, R. van der Griend, G.P. vanBerge-Henegouwen, and J.C. Koningsberger Homocysteine in inflamatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 96 2001 1301 1302
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 1301-1302
-
-
Oldenburg, B.1
Fijnheer, R.2
Van Der Griend, R.3
Vanberge-Henegouwen, G.P.4
Koningsberger, J.C.5
-
65
-
-
15944369567
-
The vasculature and inflammatory bowel disease: Contribution to pathogenesis and clinical pathology
-
O.A. Hatoum, and D.G. Binion The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology Inflamm Bowel Dis 11 2005 304 313
-
(2005)
Inflamm Bowel Dis
, vol.11
, pp. 304-313
-
-
Hatoum, O.A.1
Binion, D.G.2
-
66
-
-
0142200971
-
The vascular contribution in the pathogenesis of inflammatory bowel disease
-
O.A. Hatoum, H. Miura, and D.G. Binion The vascular contribution in the pathogenesis of inflammatory bowel disease Am J Physiol Heart Circ Physiol 285 2003 H1791 H1796
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.285
-
-
Hatoum, O.A.1
Miura, H.2
Binion, D.G.3
-
67
-
-
0031444861
-
Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease
-
C.E. Collins, D.S. Rampton, J. Rogers, and N.S. Williams Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease Eur J Gastroenterol Hepatol 9 1997 1213 1217
-
(1997)
Eur J Gastroenterol Hepatol
, vol.9
, pp. 1213-1217
-
-
Collins, C.E.1
Rampton, D.S.2
Rogers, J.3
Williams, N.S.4
-
68
-
-
0033552883
-
Atherosclerosis - An inflammatory disease
-
R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
69
-
-
17644412023
-
Inflammation, atherosclerosis and coronary artery disease
-
G.K. Hannson Inflammation, atherosclerosis and coronary artery disease N Engl J Med 352 2005 1685 1695
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hannson, G.K.1
-
70
-
-
21844451117
-
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The Cardiovascular Health Study
-
M. Cushman, A.M. Arnold, B.M. Psaty, T.A. Manolio, L.H. Kuller, and G.L. Burke C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study Circulation 112 2005 25 31
-
(2005)
Circulation
, vol.112
, pp. 25-31
-
-
Cushman, M.1
Arnold, A.M.2
Psaty, B.M.3
Manolio, T.A.4
Kuller, L.H.5
Burke, G.L.6
-
71
-
-
23944476094
-
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer
-
R. Atreya, and M.F. Neurath Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer Clin Rev Allergy Immunol 28 2005 187 196
-
(2005)
Clin Rev Allergy Immunol
, vol.28
, pp. 187-196
-
-
Atreya, R.1
Neurath, M.F.2
-
72
-
-
0037190065
-
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the women's health initiative observational study
-
A.D. Pradhan, J.E. Manson, J.E. Rossouw, D.S. Siscovick, C.P. Mouton, and N. Rifai Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women's health initiative observational study JAMA 288 2002 980 987
-
(2002)
JAMA
, vol.288
, pp. 980-987
-
-
Pradhan, A.D.1
Manson, J.E.2
Rossouw, J.E.3
Siscovick, D.S.4
Mouton, C.P.5
Rifai, N.6
-
74
-
-
0037672879
-
Case reports of heart failure after therapy with a tumor necrosis factor antagonist
-
H.J. Kwon, T.R. Cote, M.S. Cuffe, J.M. Kramer, and M.M. Braun Case reports of heart failure after therapy with a tumor necrosis factor antagonist Ann Intern Med 138 2003 807 811
-
(2003)
Ann Intern Med
, vol.138
, pp. 807-811
-
-
Kwon, H.J.1
Cote, T.R.2
Cuffe, M.S.3
Kramer, J.M.4
Braun, M.M.5
-
75
-
-
4944223125
-
Unusual toxicities with TNF inhibition: Heart failure and drug-induced lupus
-
J.J. Cush Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus Clin Exp Rheumatol 22 2004 S141 S147
-
(2004)
Clin Exp Rheumatol
, vol.22
-
-
Cush, J.J.1
-
76
-
-
33745064418
-
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
-
M.H. Schiff, G.R. Burmester, J.D. Kent, A.L. Pangan, H. Kupper, and S.B. Fitzpatrick Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis Ann Rheum Dis 65 2006 889 894
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 889-894
-
-
Schiff, M.H.1
Burmester, G.R.2
Kent, J.D.3
Pangan, A.L.4
Kupper, H.5
Fitzpatrick, S.B.6
-
77
-
-
19944433874
-
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
-
N. Feltelius, C.M. Fored, P. Blomqvist, L. Bertilsson, P. Geborek, and L.T. Jacobsson Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept Ann Rheum Dis 64 2005 246 252
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 246-252
-
-
Feltelius, N.1
Fored, C.M.2
Blomqvist, P.3
Bertilsson, L.4
Geborek, P.5
Jacobsson, L.T.6
-
78
-
-
33846278750
-
The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists
-
J. Cole, A. Busti, and S. Kazi The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists Rheumatol Int 27 2007 369 373
-
(2007)
Rheumatol Int
, vol.27
, pp. 369-373
-
-
Cole, J.1
Busti, A.2
Kazi, S.3
-
79
-
-
21244436822
-
Antirheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
-
S. Bernatsky, M. Hudson, and S. Suissa Antirheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis Rheumatology 44 2005 677 680
-
(2005)
Rheumatology
, vol.44
, pp. 677-680
-
-
Bernatsky, S.1
Hudson, M.2
Suissa, S.3
-
80
-
-
35549010225
-
Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists
-
J.R. Curtis, J.M. Kramer, C. Martin, K.g. Saag, N. Patkar, and D. Shatin Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists Rheumatology 46 2007 1688 1693
-
(2007)
Rheumatology
, vol.46
, pp. 1688-1693
-
-
Curtis, J.R.1
Kramer, J.M.2
Martin, C.3
Saag, K.G.4
Patkar, N.5
Shatin, D.6
-
81
-
-
34347251548
-
All-cause and causespecific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
-
L. Carmona, M.A. Descalzo, E. Perez-Pampin, D. Ruiz-Montesinos, A. Erra, and T. Cobo All-cause and causespecific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists Ann Rheum Dis 66 2007 880 885
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 880-885
-
-
Carmona, L.1
Descalzo, M.A.2
Perez-Pampin, E.3
Ruiz-Montesinos, D.4
Erra, A.5
Cobo, T.6
-
82
-
-
79957461056
-
Systematic review and meta-analysis: Anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis
-
C. Barnabe, B.J. Martin, and W.A. Ghali Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis Arthritis Care Res 63 2011 522 529
-
(2011)
Arthritis Care Res
, vol.63
, pp. 522-529
-
-
Barnabe, C.1
Martin, B.J.2
Ghali, W.A.3
-
85
-
-
18744380397
-
A 49-year-old male with acute superior mesenteric artery occlusion during active ulcerative colitis: Report of a case
-
R.S. Brown, S. Armen, A. Patmanaban, T.H. Hartranft, and P.D. Price A 49-year-old male with acute superior mesenteric artery occlusion during active ulcerative colitis: report of a case Dis Colon Rectum 48 2005 572 574
-
(2005)
Dis Colon Rectum
, vol.48
, pp. 572-574
-
-
Brown, R.S.1
Armen, S.2
Patmanaban, A.3
Hartranft, T.H.4
Price, P.D.5
-
86
-
-
33847253913
-
Inflammatory Bowel disease is not a risk factor for cardiovascular disease mortality: Results from a systematic review and metaanalysis
-
S.P. Dorn, and R.S. Sandler Inflammatory Bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and metaanalysis Am J Gastroenterol 102 2007 662 667
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 662-667
-
-
Dorn, S.P.1
Sandler, R.S.2
|